Enanta Pharmaceuticals SG&A Expense (TTM) Trends

Enanta Pharmaceuticals Inc (ENTA)

13.32 +0.18 (+1.37%) USD | NASDAQ | Jul 05, 15:36

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	57.17M
December 31, 2023	56.71M
September 30, 2023	52.89M
June 30, 2023	51.66M
March 31, 2023	51.97M
December 31, 2022	48.67M
September 30, 2022	45.48M
June 30, 2022	41.27M
March 31, 2022	36.82M
December 31, 2021	34.67M
September 30, 2021	32.54M
June 30, 2021	30.91M
March 31, 2021	29.25M
December 31, 2020	27.81M
September 30, 2020	27.36M
June 30, 2020	26.79M
March 31, 2020	26.12M
December 31, 2019	26.02M
September 30, 2019	26.25M
June 30, 2019	25.91M
March 31, 2019	25.90M
December 31, 2018	24.82M
September 30, 2018	23.44M
June 30, 2018	22.73M

Date	Value
March 31, 2018	21.83M
December 31, 2017	21.58M
September 30, 2017	20.75M
June 30, 2017	20.07M
March 31, 2017	19.12M
December 31, 2016	18.08M
September 30, 2016	16.97M
June 30, 2016	16.22M
March 31, 2016	15.58M
December 31, 2015	14.59M
September 30, 2015	13.54M
June 30, 2015	12.61M
March 31, 2015	11.57M
December 31, 2014	10.70M
September 30, 2014	10.02M
June 30, 2014	9.005M
March 31, 2014	8.19M
December 31, 2013	7.118M
September 30, 2013	6.183M
June 30, 2013	6.132M
March 31, 2013	5.489M
December 31, 2012	5.203M
September 30, 2012	5.302M
June 30, 2012	4.805M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

26.02M

Minimum

Dec 2019

57.17M

Maximum

Mar 2024

38.44M

Average

34.67M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks